F865-0730 Screening compound: N-(2H-1,3-benzodioxol-5-yl)-5-[4-({[1-(4-ethylphenyl)ethyl]carbamoyl}methyl)piperidine-1-carbonyl]-1,3,4-thiadiazole-2-carboxamide

F865-0730 Screening compound: N-(2H-1,3-benzodioxol-5-yl)-5-[4-({[1-(4-ethylphenyl)ethyl]carbamoyl}methyl)piperidine-1-carbonyl]-1,3,4-thiadiazole-2-carboxamide
F865-0730 Screening compound: N-(2H-1,3-benzodioxol-5-yl)-5-[4-({[1-(4-ethylphenyl)ethyl]carbamoyl}methyl)piperidine-1-carbonyl]-1,3,4-thiadiazole-2-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F865-0730
N-(2H-1,3-benzodioxol-5-yl)-5-[4-({[1-(4-ethylphenyl)ethyl]carbamoyl}methyl)piperidine-1-carbonyl]-1,3,4-thiadiazole-2-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F865-0730

Molecular Formula

C28H31N5O5S (C28 H31 N5 O5 S)

Compound Name

N-(2H-1,3-benzodioxol-5-yl)-5-[4-({[1-(4-ethylphenyl)ethyl]carbamoyl}methyl)piperidine-1-carbonyl]-1,3,4-thiadiazole-2-carboxamide

IUPAC name

N-(2H-13-benzodioxol-5-yl)-5-[4-({[1-(4-ethylphenyl)ethyl]carbamoyl}methyl)piperidine-1-carbonyl]-134-thiadiazole-2-carboxamide

SMILES

CCc1ccc(C(C)NC(CC(CC2)CCN2C(c2nnc(C(Nc(cc3)cc4c3OCO4)=O)s2)=O)=O)cc1

InChI

InChI=1S/C28H31N5O5S/c1-3-18-4-6-20(7-5-18)17(2)29-24(34)14-19-10-12-33(13-11-19)28(36)27-32-31-26(39-27)25(35)30-21-8-9-22-23(15-21)38-16-37-22/h4-9,15,17,19H,3,10-14,16H2,1-2H3,(H,29,34)(H,30,35)/t17-/m0/s1

InChI Key

MTQDOHQMZVOOED-KRWDZBQOSA-N

MDL Number (MFCD)

MFCD14969048

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

549.65

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

4.275

Distribution Coefficient, logD

4.260

Water Solubility, LogSw

-4.21

Polar Surface Area

103.961

Acid Dissociation Constant (pKa)

8.86

Base Dissociation Constant (pKb)

-0.29

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

39.30

F865-0730 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

CORONAVIRUS Library (20774 compounds)

PLpro Library (6343 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds

References: we are preparing a list of scientific research reports with F865-0730 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F865-0730?
Check Price and Availability of F865-0730, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F865-0730 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F865-0730
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F865-0730
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F865-0730 available by request